Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)
This study has been completed.
Study NCT01161602 Information provided by Edusa Pharmaceuticals, Inc.
First Received on July 12, 2010. Last Updated on September 20, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Gastroesophageal Reflux Disease
Additional conditions recognized in this trial
More general conditions related to this trial
Digestive System Diseases
Esophageal Motility Disorders
Interventions listed in this trial
Sponsors listed in this trial
Edusa Pharmaceuticals, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers